Donald trump has once again expressed interest in Canada becoming the 51st state of the United States, outlining several ...
Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...
You’ll wake up to understanding how developments in news and business across the globe overnight impacts you and affects your work day ahead in the Asia Pacific. Weekdays 7am – 10am (SIN / HK) ...